Visiona MedTech International, founded in 2013, focus on developing and distributing AI-powered retinal image analysis solutions for diseases detection. During a 3-year IncuTech Program sponsored by the Hong Kong SAR Government via the Hong Kong Science and Technology Parks Corporation, the Visiona team, with cross-discipline expertise, successfully developed VisionaDR™ by leveraging on state-of-the-art deep learning technology.
In late 2016, Visiona launched VisionaDR™, Hong Kong's first online SaaS platform, providing retinal image analysis services for automatic detection of Diabetic Retinopathy. Independent validation report released by a world's top 100 university recommends VisionaDR as safe for DR Screening practice.
VisionaDR™, a web-based image analysis service platform, enables health management services providers to offer quick and convenient DR Screening to diabetes patients virtually everywhere their fundus cameras can be taken to. It is reshaping preventive healthcare services delivery model, making DRS conveniently available to people at every corner at affordable costs.